Cargando…

Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD) are chronic medical disorders characterized by recurrent gastrointestinal inflammation. While the etiology of IBD is still unknown, the pathogenesis of the disease results from perturbations in both gut microbiota and the host immune system. Gut microbiota dysbiosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sultan, Salma, El-Mowafy, Mohammed, Elgaml, Abdelaziz, Ahmed, Tamer A. E., Hassan, Hebatoallah, Mottawea, Walid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502967/ https://www.ncbi.nlm.nih.gov/pubmed/34646151 http://dx.doi.org/10.3389/fphys.2021.715506

Ejemplares similares

Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection
por: El-Mowafy, Mohammed, et al.
Publicado: (2021)

Gut Microbiota Extracellular Vesicles as Signaling Molecules Mediating Host-Microbiota Communications
por: Sultan, Salma, et al.
Publicado: (2021)

Evidence of the Dysbiotic Effect of Psychotropics on Gut Microbiota and Capacity of Probiotics to Alleviate Related Dysbiosis in a Model of the Human Colon
por: Ait Chait, Yasmina, et al.
Publicado: (2023)

Evaluation of the Prebiotic Potential of a Commercial Synbiotic Food Ingredient on Gut Microbiota in an Ex Vivo Model of the Human Colon
por: Mottawea, Walid, et al.
Publicado: (2020)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
por: Pisani, Anthea, et al.
Publicado: (2022)

Tazemetostat decreases β-catenin and CD13 protein expression in HEPG-2 and Hepatitis B virus-transfected HEPG-2 with decreased cell viability
por: Amin, Mohamed N., et al.
Publicado: (2023)

The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis
por: Carstens, Adam, et al.
Publicado: (2019)

Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines
por: Zhou, Yanlin, et al.
Publicado: (2022)

Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
por: Alshehri, Dikhnah, et al.
Publicado: (2021)

Exercise-induced downregulation of serum interleukin-6 and tumor necrosis factor-alpha in Egyptian handball players
por: Amin, Mohamed N., et al.
Publicado: (2021)

The antimicrobial peptide alpha defensin correlates to type 2 diabetes via the advanced glycation end products pathway
por: El-Mowafy, Mohammed, et al.
Publicado: (2022)

Associations between dysbiosis gut microbiota and changes of neurotransmitters and short-chain fatty acids in valproic acid model rats
por: Zhong, Jiu-Gen, et al.
Publicado: (2023)

Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
por: Liu, Yang, et al.
Publicado: (2018)

Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling
por: Rosario, Dorines, et al.
Publicado: (2018)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis
por: Henson, Michael A., et al.
Publicado: (2017)

Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome
por: Cavalcante-Silva, Luiz H. A., et al.
Publicado: (2015)

Functional Characterization of Inflammatory Bowel Disease–Associated Gut Dysbiosis in Gnotobiotic Mice
por: Nagao-Kitamoto, Hiroko, et al.
Publicado: (2016)

Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis
por: Dahal, Ram Hari, et al.
Publicado: (2023)

Gut Microbiota Dysbiosis Influences Metabolic Homeostasis in Spodoptera frugiperda
por: Chen, Yaqing, et al.
Publicado: (2021)

The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases
por: Zou, Fei, et al.
Publicado: (2023)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Survival and Interplay of γ-Aminobutyric Acid-Producing Psychobiotic Candidates with the Gut Microbiota in a Continuous Model of the Human Colon
por: Mousavi, Rojaalsadat, et al.
Publicado: (2022)

Gut Microbiota in Inflammatory Bowel Disease
por: Shim, Jung Ok
Publicado: (2013)

The gut microbiota and inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2014)

The Gut Microbiota in Inflammatory Bowel Disease
por: Qiu, Peng, et al.
Publicado: (2022)

Inflammatory Bowel Diseases and Gut Microbiota
por: Haneishi, Yuri, et al.
Publicado: (2023)

Influence of gut microbiota dysbiosis on brain function: a systematic review
por: Almeida, Cátia, et al.
Publicado: (2020)

Matrine Mediates Inflammatory Response via Gut Microbiota in TNBS-Induced Murine Colitis
por: Li, Peiyuan, et al.
Publicado: (2019)

Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives
por: FJELDHEIM DALE, Hanna, et al.
Publicado: (2020)

Dysbiosis of Salivary Microbiota in Inflammatory Bowel Disease and Its Association With Oral Immunological Biomarkers
por: Said, Heba S., et al.
Publicado: (2014)

Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
por: Michaud, Eva, et al.
Publicado: (2022)

The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease
por: Abdelbary, Mohamed M. H., et al.
Publicado: (2022)

Dysbiosis of Fecal Microbiota From Complement 3 Knockout Mice With Constipation Phenotypes Contributes to Development of Defecation Delay
por: Choi, Yun Ju, et al.
Publicado: (2021)

Retraction: Human gut microbiota: dysbiosis and manipulation
Publicado: (2013)

Gut microbiota dysbiosis contributes to the development of hypertension
por: Li, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_een89fse7puql5qc0rkllfqcat